Frontlight ResearchEarly access
Parkinson disease trials in Mexico
1 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Mexico City
- Age
- 50 years to 85 years
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00